Evolva Holding SA – SIX:EVE.SW
Evolva Holding SA stock price today
Evolva Holding SA stock price monthly change
Evolva Holding SA stock price quarterly change
Evolva Holding SA stock price yearly change
Evolva Holding SA key metrics
Market Cap | 5.91M |
Enterprise value | 64.61M |
P/E | -1.79 |
EV/Sales | 5.91 |
EV/EBITDA | -3.55 |
Price/Sales | 5.06 |
Price/Book | 0.52 |
PEG ratio | -0.07 |
EPS | -30.03 |
Revenue | 19.69M |
EBITDA | -8.00M |
Income | -144.58M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -215.3% |
Oper. margin | -208.41% |
Gross margin | 41.15% |
EBIT margin | -208.41% |
EBITDA margin | -40.62% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEvolva Holding SA stock price history
Evolva Holding SA stock forecast
Evolva Holding SA financial statements
| Jun 2022 | 8.13M | -28.85M | -354.74% |
|---|---|---|---|
| Dec 2022 | 7.40M | -14.50M | -195.95% |
| Jun 2023 | 4.45M | -79.64M | -1788.73% |
| Dec 2023 | -295.9K | -21.57M | 7289.66% |
| 2027 | 78.2M | 0 |
|---|
Analysts Price target
Financials & Ratios estimates
| Jun 2022 | 140188200 | 25.77M | 18.39% |
|---|---|---|---|
| Dec 2022 | 131007300 | 24.76M | 18.91% |
| Jun 2023 | 53137000 | 24.32M | 45.77% |
| Dec 2023 | 9828200 | 2.69M | 27.43% |
| Jun 2022 | -13.49M | -1.24M | 11.10M |
|---|---|---|---|
| Dec 2022 | -5.38M | -523K | 3.65M |
| Jun 2023 | -3.94M | -38K | 3.29M |
| Dec 2023 | 1.23M | 18.03M | -12.83M |
Evolva Holding SA alternative data
| Aug 2023 | 50 |
|---|---|
| Sep 2023 | 50 |
| Oct 2023 | 49 |
| Nov 2023 | 49 |
| Dec 2023 | 49 |
| Jan 2024 | 49 |
| Feb 2024 | 49 |
| Mar 2024 | 49 |
| Apr 2024 | 49 |
| May 2024 | 49 |
| Jun 2024 | 49 |
| Jul 2024 | 49 |
Evolva Holding SA other data
| Insider | Compensation |
|---|---|
Mr. Oliver Walker M.B.A. (1969) Chief Executive Officer | $588,700 |
-
What's the price of Evolva Holding SA stock today?
One share of Evolva Holding SA stock can currently be purchased for approximately $0.14.
-
When is Evolva Holding SA's next earnings date?
Unfortunately, Evolva Holding SA's (EVE.SW) next earnings date is currently unknown.
-
Does Evolva Holding SA pay dividends?
No, Evolva Holding SA does not pay dividends.
-
How much money does Evolva Holding SA make?
Evolva Holding SA has a market capitalization of 5.91M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 39.27% to 9.44M US dollars.
-
What is Evolva Holding SA's stock symbol?
Evolva Holding SA is traded on the SIX under the ticker symbol "EVE.SW".
-
What is Evolva Holding SA's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Evolva Holding SA?
Shares of Evolva Holding SA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Evolva Holding SA's key executives?
Evolva Holding SA's management team includes the following people:
- Mr. Oliver Walker M.B.A. Chief Executive Officer(age: 56, pay: $588,700)
-
How many employees does Evolva Holding SA have?
As Jul 2024, Evolva Holding SA employs 49 workers.
-
When Evolva Holding SA went public?
Evolva Holding SA is publicly traded company for more then 20 years since IPO on 3 May 2005.
-
What is Evolva Holding SA's official website?
The official website for Evolva Holding SA is evolva.com.
-
How can i contact Evolva Holding SA?
Evolva Holding SA can be reached via phone at +41 61 485 20 00.
Evolva Holding SA company profile:
Evolva Holding SA
evolva.comSIX
49
Biotechnology
Healthcare
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Reinach, 4153
:
ISIN: CH1262055788
:
